
La Jolla Pharmaceutical (LJPC) Latest News & Updates
Explore latest LJPC News and Updates
Stay updated on LJPC with the latest news, market trends, and key developments to support informed investing decisions.
Start investing in LJPC
Order type
Buy in
Order amount
Est. shares
0 shares

GlobeNewsWire •

GlobeNewsWire •


Zacks Investment Research •

Zacks Investment Research •

GlobeNewsWire •

Zacks Investment Research •







Zacks Investment Research •




GlobeNewsWire •

Zacks Investment Research •

Zacks Investment Research •

24/7 Wall Street •

GlobeNewsWire •

24/7 Wall Street •

La Jolla Pharmaceutical Company Receives European Commission Approval for GIAPREZA™ (angiotensin II)
GlobeNewsWire •
